Alnylam

3 Biotech Stocks That Skyrocketed Last Week: Can They Go Higher?
Motley Fool
Mon, 09/25/17 - 09:42 am
Madrigal Pharmaceuticals
MGL-3196
Alnylam
Sanofi
Arbutus BioPharma
Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines
Stat
Wed, 09/20/17 - 09:27 am
Alnylam
rare disease
Patisiran
familial amyloid polyneuropathy
RNAi
On Eve of Big Data Reveal, Patient Death Stalls Alnylam Hemophilia Drug
Xconomy
Thu, 09/7/17 - 05:46 pm
Alnylam
fitusiran
hemophilia
3 Biotech Stocks That Could Soar in September
Motley Fool
Sun, 08/27/17 - 06:26 pm
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
Alnylam review turns up no clear answers on revusiran deaths
BioPharma Dive
Thu, 08/10/17 - 06:53 pm
Alnylam
revusiran
RNAi
3 Drug Stocks Poised to Surpass Estimates in Q2 Earnings
Yahoo/Zacks.com
Wed, 08/9/17 - 09:41 am
earnings
Puma Biotechnology
Alnylam
Impax Labs
Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug
Endpoints
Fri, 07/7/17 - 10:22 am
Sanofi
Alnylam
clinical trials
fitusiran
hemophilia
Roche
emicizumab
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Alnylam lines up Phase 3 for another RNAi drug
BioPharma Dive
Tue, 06/27/17 - 10:33 am
Alnylam
RNAi
givosiran
acute hepatic porphyrias
5 Best Biotech Stocks of 2017 So Far
Motley Fool
Mon, 06/26/17 - 09:41 am
biotech
Alnylam
Puma Biotechnology
Immunogen
Sangamo BioSciences
Calitera
​Alnylam CEO’s pay fell nearly 80 percent in 2016
Bizjournals.com
Mon, 03/20/17 - 11:28 pm
Alnylam
Pharma CEOs
John Maraganore
executive pay
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
Sun, 12/4/16 - 12:37 pm
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
Alnylam touts hemophilia drug's edge over Roche rival
BioPharma Dive
Fri, 12/2/16 - 10:48 am
Alnylam
Roche
hemophilia
fitusiran
Alnylam Pharma stock plummets 45% after discontinuing drug on patient safety concerns
Marketwatch
Thu, 10/6/16 - 09:24 am
Alnylam
clinical trials
revusiran
Alnylam shares crater after deaths force investigators to scrap PhIII RNAi drug
Endpoints
Wed, 10/5/16 - 05:19 pm
Alnylam
RNAi
clinical trials
Alnylam CEO: Four Things To Learn From Medicine Development
Forbes
Mon, 10/3/16 - 09:43 pm
Alnylam
Pharma CEOs
drug development
Could Alnylam Pharmaceuticals Change Medicine as We Know It?
Motley Fool
Tue, 05/31/16 - 09:16 am
Alnylam
RNAi
No stranger to gambling, this biotech CEO is going all-in on a first drug approval
Stat
Fri, 05/6/16 - 10:29 am
John Maraganore
Pharma CEOs
Alnylam
Alnylam reports 4Q loss
Yahoo/AP
Thu, 02/11/16 - 08:42 pm
Alnylam
earnings
Alnylam Initiates Clinical Trial, SPDR S&P Biotech Mid-Caps Plunge Anyway
Yahoo/Market Realist
Sat, 12/26/15 - 12:05 pm
Alnylam
biotech
clinical trials
ALN-CC5

Pages